Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bell

Showing results (201-210 of 1,712) with videos related to

Pageof 172
Sort By:
The American Journal of Medicine|October 1, 1993
Serum angiotensin-converting enzyme as a marker for the chronic fatigue-immune dysfunction syndrome: a comparison to serum angiotensin-converting enzyme in sarcoidosisJ Lieberman, D S Bell
Diabetes Care|May 20, 1999
Troglitazone's effect on lipoprotein(a) levelsF Ovalle, D S Bell
Diabetes Care|June 17, 2000
Late-onset troglitazone-induced hepatic dysfunctionD S Bell, F Ovalle
Lancet (London, England)|February 7, 2001
Antibodies to tumour necrosis factor alpha as treatment for Crohn's diseaseS Bell, M A Kamm
American Journal of Pharmaceutical Education|March 2, 2018
Flexner, Educational Reform, Social Accountability and Meta-CurriculumDamarys Padilla, Hershey S Bell
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 6, 2001
Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapyD S Bell, F Ovalle
Seizure|July 24, 2007
Incidence and risk factors for sudden death in the NetherlandsGail S Bell, Ley Sander
Diabetes Care|November 5, 1998
Troglitazone interferes with gemfibrozil's lipid-lowering actionD S Bell, F Ovalle
Scientific Reports|August 3, 2021
Assessing the predictability of existing water-to-enamel geolocation models against known human teethMomoko Ueda, Lynne S Bell
Expert Opinion on Therapeutic Patents|September 13, 2011
Novel phosphodiesterase type 5 modulators: a patent survey (2008 - 2010)Andrew S Bell, Michael J Palmer
Pageof 172

Showing results (201-210 of 1,712) with videos related to

Sort By:
Pageof 172
The American Journal of Medicine|October 1, 1993
Serum angiotensin-converting enzyme as a marker for the chronic fatigue-immune dysfunction syndrome: a comparison to serum angiotensin-converting enzyme in sarcoidosisJ Lieberman, D S Bell
Diabetes Care|May 20, 1999
Troglitazone's effect on lipoprotein(a) levelsF Ovalle, D S Bell
Diabetes Care|June 17, 2000
Late-onset troglitazone-induced hepatic dysfunctionD S Bell, F Ovalle
Lancet (London, England)|February 7, 2001
Antibodies to tumour necrosis factor alpha as treatment for Crohn's diseaseS Bell, M A Kamm
American Journal of Pharmaceutical Education|March 2, 2018
Flexner, Educational Reform, Social Accountability and Meta-CurriculumDamarys Padilla, Hershey S Bell
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 6, 2001
Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapyD S Bell, F Ovalle
Seizure|July 24, 2007
Incidence and risk factors for sudden death in the NetherlandsGail S Bell, Ley Sander
Diabetes Care|November 5, 1998
Troglitazone interferes with gemfibrozil's lipid-lowering actionD S Bell, F Ovalle
Scientific Reports|August 3, 2021
Assessing the predictability of existing water-to-enamel geolocation models against known human teethMomoko Ueda, Lynne S Bell
Expert Opinion on Therapeutic Patents|September 13, 2011
Novel phosphodiesterase type 5 modulators: a patent survey (2008 - 2010)Andrew S Bell, Michael J Palmer
Pageof 172